Africa: Smallpox Drug in Clinical Trials for Treating Mpox in Africa
A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic Republic of Congo and neighboring countries, starting in the fourth quarter of this year. The MpOx Study in Africa (MOSA) will evaluate the safety and […]
Africa: Smallpox Drug in Clinical Trials for Treating Mpox in Africa Read More »